Expanding the role of pharmacists in prescribing and giving them more clinical services are dependent on sustainable funding model seen in Scotland and Wales.
In an interview with Pharmacy Business, Malcolm Harrison explains how issues with medicine shortages are having a detrimental impact on patient care...
Uniphar’s 2024 profits were predominantly driven by organic growth, with Pharma and Medtech divisions delivering organic growth of 17.6% and 9.1% respectively
Numark chairman Harry McQuillan suggests shifting the remuneration model from purely supply-driven to one with more of a patient-first clinical service focus.